A systematically structured, comprehensive research publication that provides in-depth market information
This Persistence Market Research (PMR) report examines the global herpes marker testing market for the period 2017-2025. The primary objective of the report is to offer updates and information related to market opportunities in the global herpes marker testing market. To understand the market correctly, the report is categorically split into five sections viz. market analysis by test type, indication, application, end user and region.
The report analyzes the global herpes marker testing market in terms of value (US$ Mn). The report begins with the market definition and explaining the different test types along with different viral type indications. Recent developments and major global trends in the herpes marker testing market enable the client to study the overall market scenario in various regions. Test type assessment section is designed to provide an analysis of historical evolution of herpes marker testing in the market and possible future growth opportunities. The market dynamics section includes PMR’s analysis on key trends, drivers, restraints, opportunities and macro factors influencing the global market. Impact analysis of key growth drivers and restraints based on the weighted average model has also been included in the report to better equip clients with crystal clear decision making insights.
The next section of the report analyzes the market based on test type and presents the forecast in terms of value for the next eight years. Herpes marker test types covered in the report include:
The next section of the report analyzes the market based on indication and presents the forecast in terms of value for the next eight years. Indication types covered in the report include:
The next section of the report analyzes the market based on application and presents the forecast in terms of value for the next eight years. Application types covered in the report include:
The next section of the report analyzes the market based on end user and presents the forecast in terms of value for the next eight years. End user types covered in the report include:
The next section of the report analyzes the market based on region and presents the forecast in terms of value for the next eight years. Regions covered in the report include:
In the final section of the report on the global herpes marker testing market, a competitive landscape is included to provide report audiences with a dashboard view of the competitor firms. This section is primarily designed to provide clients with an objective and detailed comparative assessment of the key providers specific to a market segment in the global herpes marker testing market and participants across the value chain. Moreover, this section also includes market strategies and SWOT analysis of the major players in the market. Detailed profiles of the providers of herpes marker testing products are also included in the scope of the report to evaluate their long-term and short-term strategies.
A robust research methodology for near accurate estimation of market forecast
We have taken into consideration the year-on-year growth and incremental $ opportunity to understand the predictability of the market and to identify the right growth opportunities in the global market. Another key feature of this report is the analysis of key segments in terms of market attractiveness index. This is the combination of market share index and CAGR of individual segments and provides the incremental opportunity of a particular segment in the overall market. This parameter is very critical for assessing the level of opportunity that a player in the market can look to achieve, as well as to identify potential resources from the sales and delivery perspective of the products. The resulting index helps clients identify real market opportunities.
An introduction to the global herpes marker testing market
Herpes marker testing is done to detect the presence of the herpes simplex virus (HSV) infection in the body. Various strains of herpes simplex virus have been known to infect humans. Among these, only two are included in the scope of our study: HSV1 and HSV-2. HSV-1 generally causes orofacial diseases such as cold sores, whereas HSV-2 is responsible only for genital herpes. Diagnostic kits available for herpes marker testing include HSV-1 kits, HSV-2 kits and HSV-1/HSV-2 kits. There are various types of laboratory diagnosis methods based on sensitivity and specificity, such as viral culture method, antigen & antibody based immunoassays and PCR amplification. The end users of these test types include hospitals, diagnostic centers, clinics and academic & research institutes. The global herpes marker testing market was valued at US$ 284.9 Mn in 2016 and is projected to grow at a CAGR of 6.1% during the forecast period 2017 – 2025.
Factors impacting revenue growth of the global herpes marker testing market
The global market for herpes marker testing products is flooded with numerous regional as well as international players and is continuously evolving with various technological advancements and new product launches. The herpes marker testing market is mainly driven by the prevalence of herpes in the population, increasing government support, growing awareness, rising healthcare expenditures, new product launches and an increasing focus on evidence-based medicine. Certain factors such as poor access to diagnostic services in remote areas, insufficient R&D initiatives, pricing pressures, and stringent regulations are some of the factors restricting market revenue growth. Companies are focusing on acquisitions, mergers and new product approvals and launches for remaining competitive in the global market.
Antibody/Antigen based kits to lead global market revenue growth by test type
Based on test type, the market for herpes marker testing has been divided into viral culture test, nucleic acid amplification-based kits and antibody/antigen-based kits. The antibody/antigen-based kits segment dominates the herpes marker testing market with around 50% market share projected throughout the forecast period and is expected to remain the highest in terms of value over the forecast period owing to the huge product availability as well as high physician preference for this test type. However, the nucleic acid amplification-based kits segment is observed as the highest growing segment over the forecast period owing to the growing acceptance of PCR technology in diagnosis due to its high sensitivity, specificity and less time consumption. The nucleic acid amplification-based kits segment accounted for 22.9% share in 2016 and is projected to account for just under 24% share by 2025 end with the highest growth rate of 6.6%.
Key research findings